| PERIOD ENDING |
31-Jul-09 |
30-Apr-09 |
31-Jan-09 |
31-Oct-08 |
| Total Revenue |
211,248 |
201,614 |
214,023 |
244,711 |
| Cost of Revenue |
139,252 |
136,692 |
144,721 |
170,819 |
|
| Gross Profit |
71,996 |
64,922 |
69,302 |
73,892 |
|
| Operating Expenses |
| Research Development |
15,554 |
15,024 |
17,872 |
18,443 |
| Selling General and Administrative |
25,585 |
35,452 |
50,135 |
53,954 |
| Non Recurring |
-
|
(2,745) |
178,257 |
289,119 |
| Others |
4,835 |
4,827 |
5,871 |
7,178 |
| |
| Total Operating Expenses |
-
|
52,558 |
252,135 |
368,694 |
|
|
| Operating Income or Loss |
26,022 |
12,364 |
(182,833) |
(294,802) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
(4,427) |
14,150 |
4,861 |
(5,637) |
| Earnings Before Interest And Taxes |
21,595 |
26,514 |
(177,972) |
(300,439) |
| Interest Expense |
(988) |
4,285 |
5,361 |
6,536 |
| Income Before Tax |
22,583 |
22,229 |
(183,333) |
(306,975) |
| Income Tax Expense |
673 |
3,673 |
(1,344) |
59,663 |
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops |
21,910 |
18,556 |
(181,989) |
(366,638) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
21,910 |
18,556 |
(181,989) |
(366,638) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
$21,910 |
$18,556 |
($181,989) |
($366,638) |
|
Help
0.01 (0.07%) 
Income Statement
Reuters offers more in-depth